A woman's journey through the reproductive, transitional and postmenopausal periods of life: Impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement

Maturitas

Volumn 70, Issue 2, 2011, Pages 197-205

  Stevenson, John C ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular risk; Estrogen; Hormone replacement; Menopause; Osteoarthritis; Osteoporosis; Women's health

Indexed keywords

ESTROGEN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; ESTROGEN SYNTHESIS; ESTROGEN THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSAL SYNDROME; MENOPAUSE; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; OSTEOPOROSIS; OVARY FUNCTION; POSTMENOPAUSE; PREVALENCE; REPRODUCTION; REVIEW;

CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; MUSCULOSKELETAL DISEASES; OSTEOARTHRITIS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARY; POSTMENOPAUSE; RISK FACTORS;

EID: 80052571006     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.05.017     Document Type: Review

References (64)

1. T.R. Chakraborty, and A.C. Gore Aging-related changes in ovarian hormones, their receptors and neuroendocrine function Exp Biol Med 229 2004 977 987 (Pubitemid 39431077)
2. N.K. Wenger Coronary heart disease: an older woman's major health risk Br Med J 315 1997 1085 1090 (Pubitemid 27458407)
3. The ESHRE Capri Workshop Group Hormones and cardiovascular health in women Hum Reprod Update 12 2006 483 497
4. P.W.F. Wilson, R.B. D'Agostino, and D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847 (Pubitemid 28213628)
5. Office of National Statistics for England and Wales. Available from www.statistics.gov.uk.
6. H. Tunstall-Pedoe Myth and paradox of coronary risk and the menopause Lancet 351 1998 1425 1427 (Pubitemid 28210011)
7. P.M. Sarrel Ovarian hormones and the circulation Maturitas 12 1990 287 298 (Pubitemid 20279934)
8. R.A. Lobo Estrogen and cardiovascular disease Ann N Y Acad Sci 592 1990 286 294 (Pubitemid 20273231)
9. J.C. Stevenson HRT and the primary prevention of cardiovascular disease Maturitas 57 2007 31 34 (Pubitemid 46602887)
10. X.J. Du, R.A. Riemersma, and A.M. Dart Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function Cardiovasc Res 30 1995 161 165
11. S. Rozenberg, I. Liebens, and J. Vandromme Cardiovascular protection by estrogen: a hemodynamic mechanism Int J Fertil Menopausal Stud 39 1994 136 142
12. M. Fischer, A. Baessler, and H. Schunkert Renin angiotensin system and gender differences in the cardiovascular system Cardiovas Res 53 2002 672 677 (Pubitemid 34175260)
13. P. Collins, G.M.C. Rosano, and C. Jiang Cardiovascular protection by oestrogen: a calcium antagonist effect? Lancet 8855 1993 1264 1265 (Pubitemid 23146942)
14. O.C.E. Gebara, M.A. Mittleman, and P. Sutherland Association between increased estrogen status and increased fibrinolytic potential in the Framingham offspring study Circulation 91 1995 1952 1958
15. A.H. Lichtenstein, L.J. Appel, and M. Brands Diet and lifestyle recommendations revision 2006. A scientific statement from the American Heart Association Nutrition Committee Circulation 11 2006 82 96 (Pubitemid 44305278)
16. J. Mackay, and A. Amos Women and tobacco Respirology 8 2003 123 130 (Pubitemid 36749692)
17. E.R. Pomp, F.R. Rosendaal, and C.J.M. Doggen Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use Am J Hematol 83 2008 97 102
18. R.C. Thurston, K. Sutton-Tyrrell, S.A. Everson-Rose, R. Hess, and K.A. Matthews Hot flashes and subclinical cardiovascular disease. Findings from the study of women's health across the nation heart study Circulation 118 2008 1234 1240
19. M.K. Whiteman, C.A. Staropoli, and P.W. Langenberg Smoking, body mass, and hot flashes in midlife women Obstet Gynecol 101 2003 264 272 (Pubitemid 36170127)
20. L.M. Gerber, L.L. Sievert, K. Warren, G. Thomas, and J.E. Schwartz Hot flashes are associated with increased ambulatory systolic blood pressure Menopause 14 2007 308 315 (Pubitemid 46673483)
21. A. Pines, D.W. Sturdee, and M.H. Birkhäuser HRT in the early menopause: scientific evidence and common perceptions Climacteric 11 2008 267 272 (Pubitemid 352032239)
22. J.C. Stevenson, H.N. Hodis, J.H. Pickar, and R.A. Lobo Coronary heart disease and menopause management: the swinging pendulum of HRT Atherosclerosis 207 2009 336 340
23. J.C. Stevenson HRT and cardiovascular disease Best Pract Res Clin Obstet Gynaecol 23 2009 109 120
24. S.R. Salpeter, J.M.E. Walsh, E. Greyber, and E.E. Salpeter Coronary heart disease events associated with hormone therapy in younger and older women J Gen Intern Med 21 2006 363 366
25. E.M. Tuzcu, S.R. Kapadia, and E. Tutar High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults. Evidence from intravascular ultrasound Circulation 103 2001 2705 2710 (Pubitemid 32538786)
26. J.C. Stevenson Type and route of estrogen administration Climacteric 12 Suppl. 1 2009 86 90
27. J.E. Buster Transdermal menopausal hormone therapy: delivery through skin changes the rules Expert Opin Pharmacother 11 2010 1489 1499
28. T.B. Clarkson, and R.H. Karas Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women? Menopause 14 2007 963 967 (Pubitemid 350098651)
29. B. Baksu, I. Davas, and E. Agar Do different delivery systems of estrogen therapy influence serum lipids differently in surgically menopausal women? J Obstet Gynaecol Res 33 2007 346 352 (Pubitemid 46934556)
30. I.F. Godsland Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974 to 2000 Fertil Steril 75 2001 898 915 (Pubitemid 32401667)
31. C. Renoux, S. Dell'Aniello, E. Garbe, and S. Suissa Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study Br Med J 340 2010 c2519 10.1136/bmj.c2519
32. British Heart Foundation statistics database. Available at www.heartstats.org.
33. R. Collins, R. Peto, and S. MacMahon Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 335 1990 1534 1535
34. D.G. Carey, A.B. Jenkins, and L.V. Campbell Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM Diabetes 45 1996 633 638 (Pubitemid 26140548)
35. M. Gambacciani, M. Ciaponi, and B. Cappagli Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women J Clin Endocrinol Metab 82 1997 2414 2417
36. A. Juutilainen, S. Kortelainen, and S. Lehto Gender differences in the impact of type 2 diabetes on coronary heart disease risk Diabetes Care 27 2004 2898 2904 (Pubitemid 39565056)
37. A.E. Wluka, F.M. Cicuttini, and T.D. Spector Menopause, oestrogens and arthritis Maturitas 35 2000 183 199 (Pubitemid 30628815)
38. J.C. Stevenson, B. Lees, M. Devenport, M.P. Cust, and K.F. Ganger Determinants of bone density in normal women: risk factors for future osteoporosis? Br Med J 298 1989 924 928 (Pubitemid 19104250)
39. P.S. Hench The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis and intermittent hydrarthritis Mayo Clin Proc 13 1935 161 167
40. N.S. Latman Relation of menstrual cycle phase to symptoms of rheumatoid arthritis Am J Med 74 1983 957 960 (Pubitemid 13101574)
41. A.D. Steinberg, and B.J. Steinberg Lupus disease activity associated with menstrual cycle J Rheumatol 12 1985 816 817
42. J.A. Roman-Blas, S. Castañeda, R. Largo, and G. Herrero-Beaumont Osteoarthritis associated with estrogen deficiency Arthritis Res Ther 11 2009 241
43. S.E. Gabriel, and K. Michaud Epidemiological studies in incidence, prevalence, mortality and comorbidity of the rheumatic diseases Arthritis Res Ther 11 2009 229
44. J.C. Stevenson, and M.S. Marsh Atlas of osteoporosis 3rd ed. 2007 Informa Healthcare London
45. P. Brennan, C. Bankhead, A. Silman, and D. Symmons Oral contraceptives and rheumatoid arthritis: results from a primary care-bases incident case-control study Semin Arthritis Rheum 26 1997 817 823 (Pubitemid 27274445)
46. C. Renoux, S. Dell'Aniello, and S. Suissa Hormone replacement therapy and the risk of venous thromboembolism: a population-based study J Thromb Haemost 8 2010 979 986
47. A. Fournier Should transdermal rather than oral estrogens be used in menopausal hormone therapy?: a review Menopause Int 16 2010 23 32
48. P.Y. Scarabin Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk Lancet 362 2003 428 432
49. A.J. Silman, and J. Newman Obstetric and gynaecological factors in susceptibility to peripheral joint osteoarthritis Ann Rheum Dis 55 1996 671 673 (Pubitemid 26316293)
50. A.S. Turner, K.A. Athanasiou, C.F. Zhu, M.R. Alvis, and H.U. Bryant Biochemical effects of estrogen on articular cartilage in ovariectomized sheep Osteoarthritis Cart 5 1997 63 69 (Pubitemid 27063752)
51. M.C. Nevitt, and D.T. Felson Sex hormones and the risk of osteoarthritis in women: epidemiological evidence Ann Rheum Dis 55 1996 673 676 (Pubitemid 26316294)
52. P. Ravn, L. Warming, S. Christgau, and C. Christiansen The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy Bone 35 2004 1216 1221 (Pubitemid 39487369)
53. J.C. Stevenson on behalf of the International Consensus Group on HRT, osteoporosis and regulatory authorities Quis custodiet ipos custodes? Hum Reprod 21 2006 1668 1671
54. E.S. Siris, P.D. Miller, and E. Barrett-Connor Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the national osteoporosis risk assessment JAMA 286 2001 2815 2822 (Pubitemid 33126923)
55. J.A. Cauley, J. Robbins, Z. Chen for the Women's Health Initiative Investigators Effects of estrogen plus progestin on risk of fracture and bone mineral density. The Women's Health Initiative randomized trial JAMA 290 2003 1729 1738 (Pubitemid 37430623)
56. R.J. Santen, D.C. Allred, and S.P. Ardoin Postmenopausal hormone therapy: an Endocrine Society scientific statement J Clin Endocrinol Metab 95 Suppl 7 2010 S1 S66
57. Y.Z. Bagger, L.B. Tankó, and P. Alexandersen Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study Bone 34 2004 728 735 (Pubitemid 38393810)
58. S.K. Goh, K.Y. Yang, and J.S.B. Koh Subtrochanteric insufficiency fractures in patients on alendronate therapy J Bone Joint Surg 89 2007 349 353 (Pubitemid 46563912)
59. E.M. Antman, J.S. Bennett, and A. Daugherty Use of nonsteroidal antiinflammatory drugs. An update for clinicians. A scientific statement from the American Heart Association Circulation 115 2007 1634 1642 (Pubitemid 46648649)
60. T.D. Spector, D. Nandra, D.J. Hart, and D.V. Doyle Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford study Ann Rheum Dis 56 1997 432 434 (Pubitemid 27345263)
61. O. Johnell, and J. Kanis Epidemiology of osteoporotic fractures Osteoporos Int 16 2005 S3 S7
62. J.A. Kanis, N. Burlet, and C. Cooper European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 19 2008 339 428
63. J.A. Kanis, O. Johnell, A. Oden, C. De Laet, and D. Mellstrom Epidemiology of osteoporosis and fracture in men Calcif Tissue Int 75 2004 90 99 (Pubitemid 39166208)
64. R.O. Morris, A. Sonibare, D.J. Green, and T. Masud Closed pelvic fractures: characteristics and outcomes in older patients admitted to medical and geriatric wards Postgrad Med J 76 2000 646 650